UTHR

United Therapeutics Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth↑ 6/10
  • Value↑ 5/10
United Therapeutics sales and earnings growth
UTHR Growth
Good
  • Revenue Y/Y↑ 10.61%
  • EPS Y/Y↑ 13.96%
  • FCF Y/Y↓ -3.69%
United Therapeutics gross and profit margin trends
UTHR Profitability
Great
  • Gross margin ↑ 87.90%
  • EPS margin↑ 41.90%
  • ROIC 5Y↑ 26.92%
United Therapeutics net debt vs free cash flow
UTHR Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 88.9

United Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗